Update
$Chemomab Therapeutics(CMMB.US$Chemomab Announces Completion Of Patient Enrollment In CM-101 Phase 2 Primary Sclerosing Cholangitis Trial And Moves Up Expected Topline Readout To Midyear 2024![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
